Programmable co-delivery of the immune checkpoint inhibitor NLG919 and chemotherapeutic doxorubicin via a redox-responsive immunostimulatory polymeric prodrug carrier

por Sun, Jing-jing, Chen, Yi-chao, Huang, Yi-xian, Zhao, Wen-chen, Liu, Yan-hua, Venkataramanan, Raman, Lu, Bin-feng, Li, Song
Publicado 2017